Table I.
Week 0a
|
Week 1
|
Week 2
|
||||
---|---|---|---|---|---|---|
MiGR1 | STAT5A(1*6) | MiGR1 | STAT5A(1*6) | MiGR1 | STAT5A(1*6) | |
CD34 | 92 | 93 | 10 | 11 | 1–4 | 1–4 |
CD38 | 64 | 35 | 59 | <1 | 84 | 18 |
CD33 | 99 | 99 | 84 | 8 | 78 | 17 |
CD36 | 34 | 65 | 31 | 57 | 24 | 47 |
CD71bright | 29 | 35 | 15 | 65 | 13 | 26 |
CD45 | 99 | 99 | 88 | 14 | 95 | 7 |
GPA | <1 | 7.5 | 10 | 64 | 5 | 41 |
CD11b | 11 | 6 | 53 | 3 | 68 | 14 |
CD14 | <1 | <1 | 45 | 4 | 27 | 2 |
CD15 | <1 | <1 | 12 | 0 | 23 | 3 |
Week 0 represents analysis after 48 h of prestimulation followed by 48 h of transduction of CB CD34+ cells in QBSF with KL, FL, and TPO (100 ng/ml of each) before plating cells on MS5 stroma. Data represent the average percentages of two to five independent experiments.